The miR-625-3p/AXL axis induces non-T790M acquired resistance to EGFR-TKI via activation of the TGF-β/Smad pathway and EMT in EGFR-mutant non-small cell lung cancer

相似書籍

• The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
  由: Zhang, Yang, et al.
  出版: (2019)
• Anlotinib can overcome acquired resistance to EGFR‐TKIs via FGFR1 signaling in non‐small cell lung cancer without harboring EGFR T790M mutation
  由: Lian, Zengzhi, et al.
  出版: (2020)
• Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
  由: Fu, Yulong, et al.
  出版: (2020)
• EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
  由: Zhu, Xuan, et al.
  出版: (2019)
• T790M and acquired resistance of EGFR TKI: a literature review of clinical reports
  由: Ma, Chunyan, et al.
  出版: (2011)